CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

Conditions:   Advanced Renal Cell Carcinoma (All Subtypes);   Metastatic Renal Cell Carcinoma (All Subtypes) Intervention:   Other: Documentation Sponsor:   IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials